HPV16 ctDNA assay predicts treatment response in metastatic head and neck cancer

By | August 2, 2021
Oncotarget published “Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma” which reported that despite the rising incidence of human papillomavirus related oropharyngeal squamous cell carcinoma, treatment of metastatic disease remains palliative.